Displaying 141 - 160 of 4420
FTC to Host Virtual Roundtable on AI and Content Creation
Date
The Federal Trade Commission staff will be hosting a virtual roundtable discussion on October 4, 2023 to better understand the impact of the use of generative artificial intelligence on music...
FTC Challenges Private Equity Firm’s Scheme to Suppress Competition in Anesthesiology Practices Across Texas
Date
The Federal Trade Commission today sued U.S. Anesthesia Partners, Inc. (USAP), the dominant provider of anesthesia services in Texas, and private equity firm Welsh, Carson, Anderson & Stowe, alleging...
U.S. Anesthesia Partners, Inc., FTC v.
Type of Action
Federal
Last Updated
FTC Matter/File Number
2010031
Case Status
Pending
FTC, Department of Labor Partner to Protect Workers from Anticompetitive, Unfair, and Deceptive Practices
Date
The Federal Trade Commission and the U.S. Department of Labor (DOL) signed a new agreement that will bolster the FTC’s efforts to protect workers by promoting competitive U.S. labor markets and...
FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’
Date
The Federal Trade Commission today issued a policy statement , supported by the U.S. Food and Drug Administration (FDA), warning pharmaceutical companies that make and sell brand-name drugs that they...
Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book
Date
Matter Number
P233900
File
Text of the Policy Statement
(633.47 KB)
Federal Register Notice
Amgen Inc. and Horizon Therapeutics plc; Analysis of Agreement Containing Consent Order To Aid Public Comment
Date
FTC Announces Tentative Agenda for September 14 Open Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, September 14, 2023. The open meeting will commence at 11 a.m. ET...
Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition
Date
The Federal Trade Commission reached a proposed consent order with Amgen Inc. to address the potential competitive harm that would result from Amgen’s $27.8 billion acquisition of Horizon Therapeutics...
FTC and DOJ to Co-Host 2023 Draft Merger Guidelines Workshop on September 5
Date
WHAT: The Federal Trade Commission and Justice Department are co-hosting a workshop to facilitate public dialogue on the 2023 Draft Merger Guidelines . WHEN: Tuesday, September 5, 2023, 1 p.m. – 4:15...
FTC Secures Settlement with ICE and Black Knight Resolving Antitrust Concerns in Mortgage Technology Deal
Date
The Federal Trade Commission today approved a proposed consent order to resolve antitrust concerns surrounding Intercontinental Exchange, Inc.’s (ICE) proposed $13.1 billion acquisition of Black...
FTC and DOJ Announce Workshops on the 2023 Draft Merger Guidelines
Date
The Federal Trade Commission and Justice Department announced today that they are co-hosting three workshops to facilitate public dialogue on the 2023 Draft Merger Guidelines the agencies announced in...
FTC Chair Khan Names Henry Liu as the Agency’s Bureau of Competition Director
Date
Federal Trade Commission Chair Lina M. Khan has appointed Henry Liu to serve as Director of the FTC’s Bureau of Competition. “I’m excited to have Henry at the helm of the Bureau of Competition,” said...
FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal
Date
The Federal Trade Commission today took action to resolve antitrust concerns surrounding a $5.2 billion cash-and-stock deal between private equity firm Quantum Energy Partners and natural gas producer...
Federal Register Notice
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Contact Lens Rule)
Date
Displaying 141 - 160 of 4420